Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D5ZU
|
|||
| Former ID |
DNC001567
|
|||
| Drug Name |
QPI-1002
|
|||
| Drug Type |
siRNA drug
|
|||
| Indication | Renal transplantation [ICD-11: NE84] | Phase 3 | [1] | |
| Renal artery disease [ICD-11: BD40.2; ICD-10: I70.1] | Phase 1/2 | [2] | ||
| Therapeutic Class |
siRNA
|
|||
| Company |
Quark Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | ClinicalTrials.gov (NCT00802347) I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation. U.S. National Institutes of Health. | |||
| REF 3 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.